[Angioma serpiginosum following the lines of Blaschko--an effective treatment with the IPL technology].

Klinik für Dermatologie, Venerologie und Allergologie, Universitätsklinikum Mannheim, Ruprecht-Karls-Universität Heidelberg, Mannheim.
Journal der Deutschen Dermatologischen Gesellschaft (Impact Factor: 1.4). 09/2006; 4(8):650-3. DOI: 10.1111/j.1610-0387.2006.06013.x
Source: PubMed

ABSTRACT Angioma serpiginosum, first described by Hutchinson in 1889, is a rare benign vascular nevus with dilatation and proliferation of the capillaries in the upper dermis. A 15-year-old boy presented with an angioma serpiginosum on the right side of the body following the lines of Blaschko. Both the clinical pattern and the appearance in a male are unusual. Treatment with IPL technology (intense pulsed light), which emits polychromatic light from a high-intensity flashlamp, proved to be an effective approach.

  • [Show abstract] [Hide abstract]
    ABSTRACT: The Food and Drug Administration (FDA) has approved intense pulsed light (IPL) devices for the treatment of a variety of benign pigmentary and vascular lesions, but the range of disease amenable to IPL treatment continues to expand, and there are no evidence-based clinical guidelines for its use in FDA-approved and off-label indications. To provide evidence-based recommendations to guide physicians in the application of IPL for the treatment of dermatologic disease. A literature search of the CENTRAL (1991 to May 6, 2013), EMBASE (1974 to May 6, 2013), and MEDLINE in-process and nonindexed citations and MEDLINE (1964 to present) databases was conducted. Studies that examined the role of IPL in primary dermatologic disease were identified, and multiple independent investigators extracted and synthesized data. Recommendations were based on the highest level of evidence available. Level 1 evidence was found for the use of IPL for the treatment of melasma, acne vulgaris, and telangiectasia. Level 2 evidence was found for the treatment of lentiginous disease, rosacea, capillary malformations, actinic keratoses, and sebaceous gland hyperplasia. Level 3 or lower evidence was found for the treatment of poikiloderma of Civatte, venous malformations, infantile hemangioma, hypertrophic scars, superficial basal cell carcinoma, and Bowen's disease. IPL is an effective treatment modality for a growing range of dermatologic disease and in some cases may represent a treatment of choice. It is typically well tolerated. Further high-quality studies are required.
    Dermatologic Surgery 02/2014; · 1.87 Impact Factor
  • Source
    International journal of dermatology 04/2014; · 1.18 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Im dermatologischen Alltag begegnet uns Licht auf vielfältige Weise. Die biologischen und physikalischen Interaktionen des Lichtes mit der Haut machen Licht bei gezielter Anwendung zu einem potenten Diagnostikum und Therapeutikum. Diese Arbeit soll die Einsatzmöglichkeiten von Lichtdioden und hochenergetischen Blitzlampen in der Dermatologie beleuchten. Beide Lichtquellen finden erst seit jüngerer Zeit Anwendung in der Dermatologie und bereichern neben Breitband-UV-(Ultraviolett-)Lichtquellen, Hochdruckgasentladungslampen und Halogenlampen das Armamentarium der inkohärenten Lichtquellen. In the everyday practice of dermatology, we encounter light in many ways. The biological and physical interactions between light and skin make light a potent diagnostic and therapeutic tool when well directed. This contribution intends to illuminate the possible uses of light-emitting diodes and high-energy flashlamps in dermatology. Both sources of light have only recently been employed in dermatology and in addition to broadband ultraviolet (UV) light sources, high-pressure gas discharge lamps, and halogen lamps enrich the armamentarium of incoherent light sources.
    Der Hautarzt 02/2010; 61(2):153-166. · 0.50 Impact Factor


Available from
Sep 16, 2014